The Secretary may make the following additional clinical guidance available on the Department’s website:

1. A. Any available opioid overdose reversal drug formulations, corresponding prescribing templates, and any standing order for these drugs; and
2. B. Any other applicable information deemed necessary by the Secretary.

Authority: Health-General Article, §§2-104(b), 13-3501, and 13-3502, Annotated Code of Maryland

Effective date: June 17, 2019 (46:12 Md. R. 544)